TrialDiabetic medicine : a journal of the British Diabetic Association2021

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.

M Piazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.